On vascular calcification prevention with phosphonoformate and bisphosphonates

Kidney International

Volumn 75, Issue 12, 2009, Pages 1355-1356

  Villa Bellosta, Ricardo ^a   Sorribas, Víctor ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; FOSCARNET; PHOSPHATE; PYROPHOSPHATE;

BLOOD VESSEL CALCIFICATION; CELL ACTIVITY; CELL METABOLISM; CYTOTOXICITY; DRUG INHIBITION; DRUG MECHANISM; HUMAN; LETTER; PHOSPHATE TRANSPORT; PRIORITY JOURNAL; SIDE EFFECT;

EID: 66749091090     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.108     Document Type: Letter

References (5)

1. Villa-Bellosta R, Sorribas V. Role of rat sodium/phosphate cotransporters in the cell membrane transport of arsenate. Toxicol Appl Pharmacol 2008; 232: 125-134.
2. Villa-Bellosta R, Bogaert YE, Levi M et al. Characterization of phosphate transport in rat vascular smooth muscle cells: implications for vascular calcification. Arterioscler Thromb Vasc Biol 2007; 27: 1030-1036.
3. Giachelli CM. The emerging role of phosphate in vascular calcification. Kidney Int 2009; 75: 890-897.
4. Villa-Bellosta R, Sorribas V. Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition. Arterioscler Thromb Vasc Biol 2009; doi:10.1161/ ATVBAHA.108.183384 (in press).
5. Lomashvili KA, Monier-Faugere MC, Wang X et al. Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int 2009; 75: 617-625.